Alzamend Neuro, Inc. (Nasdaq: ALZN), a clinical-stage biopharmaceutical company, today announced it will present a poster at the Society of Toxicology (SOT) Annual Meeting and ToxExpo, which will be held…
The holiday season is the ideal time to slow down, reflect, and prioritize self-care. While celebrating with loved ones, there’s no greater gift than taking the time to invest in…
KARL STORZ USA is proud to announce that its VITOM® eagle exoscope with ARTip CRUISE® motorized holding system has been awarded the Innovative Technology designation by Vizient, Inc., the leading…
Rockwell Medical, Inc. (Nasdaq: RMTI), a healthcare company specializing in the development, manufacturing, commercialization, and distribution of hemodialysis products, announced today that it has entered into a product purchase agreement…
Viz.ai, a leader in AI-driven disease detection and care coordination, has partnered with Avicenna.AI, a prominent provider of AI-powered medical imaging solutions, to integrate Avicenna.AI’s CINA-iPE and CINA-ASPECTS tools into…
Trinity Life Sciences, a leader in strategy, insights, and analytics for the life sciences sector, has launched a dedicated Marketing Communications Insights (MarCom Insights) Center of Excellence (COE). This COE…
True You Weight Loss, the nation’s first dedicated endobariatric weight loss center, has announced two new FDA-authorized clinical trials focused on providing innovative, non-surgical weight loss solutions without relying on…
MultiPlan Corporation (NYSE: MPLN), a leading provider of data-driven cost management solutions, has announced the launch of CompleteVue™, an innovative software platform designed to help health systems and healthcare providers…
Centene Corporation (NYSE: CNC), a leading healthcare enterprise focused on improving the lives of its members, has provided its financial guidance for 2025 during its investor day event. The company…
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive…
Geron Corporation (Nasdaq: GERN), a biopharmaceutical company focused on blood cancer treatments, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has…
NeoGenomics, Inc. (NASDAQ: NEO), a leader in oncology testing services, has announced the publication of a new study in ESMO Open. The study highlights the potential of circulating tumor DNA…